Temporal Arteritis News Today

Giant Cell Arteritis (GCA) or Temporal Arteritis is a condition where arteries those supplying to the head region get inflamed. The causes of Temporal Arteritis are not known.

Area under the curve for routine biomarkers distinguished infected and noninfected adults with inflammatory diseases.

Results from a pilot study examining a shortened prednisone taper of 8 weeks’ length rather than 26 weeks suggest it may be possible to reduce patients duration of exposure to glucocorticoids.

Envisioning the next generation of medical assistants

Patients with aortic inflammation detected by PET were at greater risk for developing aortic aneurysms, particularly thoracic aortic aneurysms.

Giant Cell Arteritis (GCA) or Temporal Arteritis is a condition where arteries those supplying to the head region get inflamed. The causes of Temporal Arteritis are not known.

The manufacturer of olokizumab is expected to file for approval in the United States early next year, and the drug could add a new option for patients for whom methotrexate alone doesnt work.

Fast-track clinics are using vascular ultrasound to streamline diagnosis of giant cell arteritis, but the United States has a way to go to catch up to Europe.

There was a substantial effect size for secukinumab vs placebo in sustaining remission for patients with giant cell arteritis, but a steroid-tapering protocol likely amplified the effect.

Press release content from NewMediaWire. The AP news staff was not involved in its creation. ReVision Review: Is This Vision Supplement For Eyesight Legit? Fusion PRJanuary 2, 2021 GMT New York - ( NewMediaWire ) - January 1, 2021 - With aging, all our body organs, including the brain and eyes, degenerate. The brainpower and vision we have at the age of 25 are never the same when we are 50 years old. Also, with age, we may develop many eye problems like Presbyopia, Macular degeneration, Tempora...